PharmaNutra SpA (FRA:761) FFO


FRA:761 PharmaNutra SpA FRA:761
95 GF Score
Price €85.90
GF Value €69.94
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is PharmaNutra SpA FFO?

FFO (Funds from operations) only applies to REITs.

FRA:761
95GF Score
PharmaNutra SpA FRA:761
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is PharmaNutra SpA (FRA:761) Overvalued in 2026?

Based on GuruFocus' analysis, PharmaNutra SpA stock appears to be overvalued. The current stock price of €85.90 is trading 22.8% above its estimated GF Value™ of €69.94. GuruFocus considers PharmaNutra SpA to be Modestly Overvalued.

Key valuation signals for FRA:761:

  • FFO:
  • GF Value™: €69.94 vs. price of €85.90 (22.8% above fair value)
  • GF Score™: 95/100 with 6 warning signs

No single metric tells the full story. See the FRA:761 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PharmaNutra SpA Business Description

Other Exchanges PHN:ItalyPHNm:UK
Address Via Campodavela 1, Pisa, ITA, 56122
PharmaNutra SpA is a pharmaceutical company. The company is engaged in the research, design, development, and marketing of nutraceutical supplements and medical devices. The products of the company include SiderAL Folic, UltraMag, Cetilar, and others. The company operates in Europe, the Middle East, South America, the Far East, and other regions.
95GF Score

Get the complete analysis for FRA:761

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€85.90
Price
€69.94
GF Value